INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses On Their Investment In Fermi Inc. Of Class Action Lawsuit And Upcoming Deadlines - FRMI
The class action concerns whether Fermi and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until March 6, 2026 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Fermi securities pursuant and/or traceable to Fermi's initial public offering (“IPO”). A copy of the Complaint can be obtained at .
[Click here for information about joining the class action]On or around October 1, 2025, Fermi completed its initial public offering (“IPO”) of 32.5 million shares priced at $21.00 per share. Then, on December 12, 2025, Fermi announced that the first potential tenant for the Company's Project Matador data center campus had terminated its $150 million Advance in Aid of Construction Agreement, which would have supplied construction costs for the facility. Since the IPO, Fermi's share price has fallen sharply, damaging investors.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
...
646-581-9980 ext. 7980
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment